Thursday, October 31st, 2013
Do You Have Diabetes?
Are you over age 30 (or over 20 if Native American)?
Were you diagnosed with diabetes within the last 5 years?
Is metformin your only diabetes medication?
If so, you may be able to participate in the GRADE study, a clinical research trial trying to determine the BEST long-term drug treatment for people with type 2 diabetes.
As a GRADE study participant, you will:
• Attend 1 screening visit at the Diabetes Care Center,
University of Washington Medical Center: 206-598-4978
• Visit the Seattle VA Hospital for 4 free medical appointments, 1 scheduled every 3 months, each year (for up to 7 years) of study participation
• Receive free medication and supplies for diabetes care
• Receive free exams and lab tests for diabetes care
• Receive $25 per study visit
• Receive annual diabetes education
• Become part of the nationwide Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), in collaboration with 37 nationwide medical clinics (including the Diabetes Research Group at the UW and VA Hospital in Seattle), is conducting the GRADE Study.
The goal of the GRADE Study is to find the best long-term, combination drug treatment for people with type 2 diabetes. Metformin is the usual first-line diabetes drug, but most people treated with metformin eventually need a second diabetes drug. The American Diabetes Association (ADA) recommends 4 FDA-approved diabetes drugs for potential second-line use. However, there is a question about which of the 4 is best for long-term diabetes control when combined with metformin. The GRADE Study aims to answer this question!
To learn more about your eligibility to join the GRADE study, and to learn more about the study itself, please contact the Diabetes Care Center at 206-598-4978 or visit: https://grade.bsc.gwu.edu